SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 98 filers reported holding SAGENT PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $8,331,000 | +1218.2% | 684,585 | +1623.1% | 0.05% | +1125.0% |
Q4 2015 | $632,000 | +50.5% | 39,731 | +129.8% | 0.00% | +33.3% |
Q2 2015 | $420,000 | -53.2% | 17,290 | -55.2% | 0.00% | -57.1% |
Q1 2015 | $897,000 | -90.6% | 38,600 | -91.8% | 0.01% | -94.6% |
Q3 2013 | $9,549,000 | +0.8% | 468,109 | +3.7% | 0.13% | -18.9% |
Q2 2013 | $9,470,000 | – | 451,370 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SENZAR ASSET MANAGEMENT, LLC | 453,392 | $11,022,000 | 1.89% |
GREAT POINT PARTNERS LLC | 141,900 | $3,450,000 | 1.34% |
Penn Capital Management Company, LLC | 1,247,428 | $30,325,000 | 1.25% |
Ranger Investment Management | 982,240 | $23,878,000 | 1.16% |
HealthCor Management, L.P. | 912,381 | $22,180,000 | 1.12% |
Piermont Capital Management Inc. | 138,380 | $3,364,000 | 1.02% |
JW Asset Management, LLC | 111,630 | $2,714,000 | 0.82% |
SECTORAL ASSET MANAGEMENT INC | 465,625 | $11,319,000 | 0.47% |
ACUTA CAPITAL PARTNERS, LLC | 28,000 | $681,000 | 0.42% |
Tekla Capital Management LLC | 409,500 | $9,955,000 | 0.36% |